Do certain medications work better in some races due to their genetic make-up? Though the link between race, genes, and drug response has yet to be proven, markets are starting to develop around the idea that racially tailored therapies are going to be an important part of medicine's future. CGS' Osagie Obasogie and UC Berkeley Bioethics Professor David Winickoff take a critical look at these developments in an article published on the Bioethics Forum. They suggest ways for federal regulators to grapple with the pros and cons of the "racial pharmacy."